for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Orbimed Advisors Reports Stake In Fusion Pharmaceuticals Of 7.2%

July 7 (Reuters) - Fusion Pharmaceuticals Inc:

* ORBIMED ADVISORS- REPORTS STAKE IN FUSION PHARMACEUTICALS OF 7.2% AS OF JUNE 30, 2020 - SEC FILING Source text for Eikon: [ID: bit.ly/2AArSqM] Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up